| Authors: |
Giachino C; Institut Imagine, INSERM UMR1163, Paris, France.; Neuropharmacology Laboratory, Oasi Research Institute-IRCCS, Troina, Italy.; Department of Biomedical and Biotechnological Sciences, Pharmacology Section, University of Catania, Italy., Bertoli F; Institut Imagine, INSERM UMR1163, Paris, France.; Mitochondria and Inflammation in Neurodegenerative Diseases, DZNE, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Germany., Tirolo C; Neuropharmacology Laboratory, Oasi Research Institute-IRCCS, Troina, Italy., Giuliano C; Mitochondria and Inflammation in Neurodegenerative Diseases, DZNE, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Germany., Mearelli M; Mitochondria and Inflammation in Neurodegenerative Diseases, DZNE, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Germany., Jakobi M; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., L'Episcopo F; Neuropharmacology Laboratory, Oasi Research Institute-IRCCS, Troina, Italy., Deleidi M; Institut Imagine, INSERM UMR1163, Paris, France.; Mitochondria and Inflammation in Neurodegenerative Diseases, DZNE, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Germany. |
